◆◇學術研討會◆◇ 「生技與製藥-由實驗室至市場」研討會 時間:五月十二日∼十四日 地點:學術活動中心 主辦單位:生化所、DBPS、BACAS、ABMAC、BDA、DCB、ITRI 、NHRI、TPMA 五月十二日 09:00∼09:45 Opening Ceremony and Welcoming Remarks Y.C. Cheng, C.C. Liew, Shing Chang, Cheng-Wen Wu, Yuan Tseh Lee, Han M.Hsia Session I The Evolving Pharmaceutical Technologies Chair:Horace H. Loh, Xiao Fan Wang 10:00∼10:30 Augustine Lin:Array Synthesis & Rapid Identification of Immunosuppressive Lead Compounds from in vitro Generated Chemical Library 10:30∼11:00 Ko-Chung Lin:Peptidomimetic Drug Design 11:00∼11:30 Kenneth Fong:Study of Gene Expression Using Subtractive Hybridization 11:30∼12:00 Lan Bo Chen:Positively-Charged Organelle-Specific Anti-Cancer Agents and Negatively-Charged Organ-Specific Anti-HIV Agents 13:00∼13:30 Paul O.P. Ts'o:Organ-Targeted Drug Delivery System-Liver 13:30∼14:00 Ming-Chu Hsu:Drug Discovery:From Basic Research to the Clinic 14:00∼14:30 Thomas Teen-Meei Wang:Screening New Bioactive Compounds from Taiwan's Actinomycetes 15:00∼15:30 Jacob Plattner:Discovery & Development of Ritonavir-A Novel Drug Against HIV Protease 15:30∼16:00 Tien-Wen Wiedmann:Integrating Modern Science and Traditional Chinese Medicine for New Drug Development 16:00∼16:30 Mou-Ying Fu Lu:GLP in the US:An Update and Trend 16:30∼17:00 John Wing-Sun Chow:Technology Management 五月十三日 Session II Intellectual Properties & Access to Products & Technologies Chair:Paul Ts'o, K.C. Chen 08:30∼09:00 Neil Flanzraich:Patent Strategies & Corporate Alliances for the Pharmaceutical lndustry 09:00∼09:30 Mona Wan:Alliances Between Universities & Industry 09:30∼10:00 Nancy Chang:Alliances Between Biotech and Multinational Pharmaceutical Companies 10:00∼10:30 Yi Zeng:Relationship Between Industry & Research Institutes in Mainland China Session III Marketing Approval of Drugs:Related lssues in Regulatory Affairs and Clinical Trials Chair:Darrell Liu,Wei-chi Liao Regulatory Related lssues(Moderator:Darrell Liu) 10:45∼11:10 Keith Chan:Generic Drug Approval 11:10∼11:35 Mei-Ling Hsiao:Drug Approval lssues in Taiwan 11:35∼12:00 Bruce Polsky:Rx to OTC lssues in the US 13:00∼13:30 Shaw T. Chen:Clinical Development of Botanicals:New Regulatory Approaches 13:30∼14:00 Yuan Lin:Characterization and Standardization of Phytopharmaceuticals Round Table on "Clinical Trials"(Moderator:Wei-chi Liao) Theme I 14:00∼14:50 Harmonization of Good Clinical Practice Guidelines in Asia(Emphasis in ICH/APEC)Panel Leader:Hau-Sung Kuo Theme II 15:20∼16:10 Contract Research Organizations, Data Management in Asia(Emphasis in the business aspects)Panel Leader:T.Y. Lee Theme III 16:10∼17:00 Clinical Research Conduct in Asia(Emphasis in facility, resources and training) Panel Leader:Jacqueline Whang-Peng 五月十四日 Session IV Marketing Opportunities & Strategies Chair:Hardy Chan, C.W. Lee 08:30∼08:55 Xin Yuan Liu:Biotech Venture Experience in Mainland China from on Academician's Point of View 08:55∼09:20 Xiucai Liu:Marketing Opportunities & Strategies in Mainland China 09:20∼09:45 Ming-haw Liu:Pharmaco-economics and its lmpact on the Pharmaceutical lndustry 09:45∼10:10 Vincent Lee:Opportunities Based on New Delivery Technologies 10:30∼12:00 Round Table on "Opportunities in the Current Environment" Session V Government Initiatives, Policy & Cooperation Chair:Johnsee Lee, Chii-Ming Yii 14:00∼14:25 Weichen Tien:Promotion of Biotechnology in Taiwan 14:25∼14:50 Sharlin E.Yeh:Policies on Taiwan's Bio/Pharma Industry's Development 14:50∼15:15 Cheng-Wen Wu:An Introduction to National Health Research Institute 15:30∼17:00 Round Table on "What's Needed to Fuel the Growth of the Bio/Pharmaceutical lndustry"